Apimeds Pharmaceuticals US, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2022 | — | $-713.6K | $6.2K |
| Dec 2023 | — | $31.9K | $410.5K |
| Mar 2024 | — | $-264.6K | $147.4K |
| Jun 2024 | — | $-714.0K | $63.3K |
| Sep 2024 | — | $-1.0M | $26.6K |
| Dec 2024 | — | $-1.4M | $3.5K |
| Mar 2025 | — | $-1.8M | $250.4K |
| Jun 2025 | — | $9.7M | $8.7M |
| Sep 2025 | — | $8.2M | $7.0M |
| Dec 2025 | — | $153.3M | $1.6M |
| Mar 2026 | — | $126.5M | $979.5K |
| Jun 2026 | — | $106.4M | $278.4K |